TP53 and metastatic malignant neoplasm in the lymph nodes: In conclusion, our findings indicate that positive p53 expression is independently and significantly associated with poorer 5-year survival, more advanced TNM stages, lymph node metastasis, and distant metastasis in patients with EC.